Contineum Therapeutics Class A Common Stock Statistics Share Statistics Contineum Therapeutics Class A Common Stock has 28.04M
shares outstanding. The number of shares has increased by 8.78%
in one year.
Shares Outstanding 28.04M Shares Change (YoY) 8.78% Shares Change (QoQ) 8.39% Owned by Institutions (%) 53.51% Shares Floating 20.33M Failed to Deliver (FTD) Shares 932 FTD / Avg. Volume 0.37%
Short Selling Information The latest short interest is 1.2M, so 4.28% of the outstanding
shares have been sold short.
Short Interest 1.2M Short % of Shares Out 4.28% Short % of Float 6.17% Short Ratio (days to cover) 4.77
Valuation Ratios The PE ratio is -6.71 and the forward
PE ratio is -4.53.
Contineum Therapeutics Class A Common Stock's PEG ratio is
0.02.
PE Ratio -6.71 Forward PE -4.53 PS Ratio 0 Forward PS 185.5 PB Ratio 1.43 P/FCF Ratio -8.5 PEG Ratio 0.02
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Contineum Therapeutics Class A Common Stock.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 20.69,
with a Debt / Equity ratio of 0.03.
Current Ratio 20.69 Quick Ratio 20.69 Debt / Equity 0.03 Debt / EBITDA -0.15 Debt / FCF -0.19 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.03M Employee Count 41 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -24.39% in the
last 52 weeks. The beta is 1.29, so Contineum Therapeutics Class A Common Stock's
price volatility has been higher than the market average.
Beta 1.29 52-Week Price Change -24.39% 50-Day Moving Average 10.61 200-Day Moving Average 7.5 Relative Strength Index (RSI) 60.81 Average Volume (20 Days) 253,257
Income Statement
Revenue n/a Gross Profit n/a Operating Income -50.89M Net Income -42.26M EBITDA -42M EBIT -42.26M Earnings Per Share (EPS) -2.18
Full Income Statement Balance Sheet The company has 21.94M in cash and 6.26M in
debt, giving a net cash position of 15.68M.
Cash & Cash Equivalents 21.94M Total Debt 6.26M Net Cash 15.68M Retained Earnings -117.4M Total Assets 182.89M Working Capital 169.63M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -32.84M
and capital expenditures -514K, giving a free cash flow of -33.36M.
Operating Cash Flow -32.84M Capital Expenditures -514K Free Cash Flow -33.36M FCF Per Share -1.72
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
